KeyBank National Association’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-5,903
| Closed | -$262K | – | 965 |
|
|
2018
Q3 | $262K | Sell |
5,903
-1,760
| -23% | -$78.1K | ﹤0.01% | 935 |
|
|
2018
Q2 | $300K | Buy |
7,663
+3,787
| +98% | +$148K | ﹤0.01% | 876 |
|
|
2018
Q1 | $280K | Sell |
3,876
-1,115
| -22% | -$80.5K | ﹤0.01% | 894 |
|
|
2017
Q4 | $329K | Hold |
4,991
| – | – | ﹤0.01% | 864 |
|
|
2017
Q3 | $250K | Sell |
4,991
-1,863
| -27% | -$93.3K | ﹤0.01% | 967 |
|
|
2017
Q2 | $317K | Sell |
6,854
-334
| -5% | -$15.4K | ﹤0.01% | 935 |
|
|
2017
Q1 | $254K | Sell |
7,188
-5,503
| -43% | -$194K | ﹤0.01% | 1015 |
|
|
2016
Q4 | $159K | Buy |
+12,691
| New | +$159K | ﹤0.01% | 1099 |
|
|
2016
Q2 | – | Sell |
-10,599
| Closed | -$179K | – | 1107 |
|
|
2016
Q1 | $179K | Buy |
+10,599
| New | +$179K | ﹤0.01% | 1046 |
|
|
2015
Q3 | – | Sell |
-3,691
| Closed | -$302K | – | 1160 |
|
|
2015
Q2 | $302K | Buy |
3,691
+415
| +13% | +$34K | ﹤0.01% | 1003 |
|
|
2015
Q1 | $303K | Buy |
+3,276
| New | +$303K | ﹤0.01% | 1012 |
|
|
2014
Q1 | – | Sell |
-10,693
| Closed | -$147K | – | 1271 |
|
|
2013
Q4 | $147K | Buy |
+10,693
| New | +$147K | ﹤0.01% | 1230 |
|